Aptar Pharma, a leading drug delivery systems provider, is pleased to showcase its commitment to meeting new market trends at CPhI Worldwide this year. The world’s largest pharma trade show, held 9 – 11 October in Madrid, will see more than 100,000 pharmaceutical professionals coming together for exhibitions, conferences and online communities, and this year Aptar Pharma will be showcasing an industry first with its PureHale device – a new portable drug delivery device designed for upper respiratory care – at stand 4D10.
In addition to PureHale, AptarPharma will also reveal:
- A range of new connected drug delivery devices designed to help increase dose adherence and improve patient health outcomes
- A portfolio of gamma-sterilized drug delivery components to reduce bioburden
- Aptar Pharma’s Support Services initiative, a portfolio of stage-specific development packages to help customers in their journey from molecule to market
Along with showcasing its range of innovative drug delivery devices that address nasal, pulmonary, eye care, injectables and dermal drug delivery routes at Aptar Pharma’s exhibit stand, the company will also be sharing various new solutions in prescription and over-the-counter treatments.
Furthermore, Aptar Pharma executives will be delivering three Pharma Insight Briefings outlining the latest trends, technology and product innovations:
“Debunking the leachable myths of gamma sterilization: A migration study of steam vs gamma” – Julie D. Suman, R.Ph., Ph.D., President of Next Breath, a division of Aptar Pharma. Tuesday, 9 October, 11:50-12:20.
“Portable care for your respiratory tract: Exploring new technology platforms” – Guenter Nadler, Director Business Development, Aptar Pharma. Tuesday, 9 October, 12:30-13:00.
“Building a connected devices eco-system for digital medicines” – Sai Shankar, Director Business Development, Aptar Pharma. Wednesday, 10 October, 13:50-14:20.
Aptar Pharma’s team of experts will be on hand at our booth 4D10 to explain and demonstrate their latest drug delivery technologies and to discuss ways they can partner with customers to ensure their drug delivery challenges are met.
View the full press release for more information about Aptar Pharma’s presence at CPhI Worldwide 2018.